To make Universal Health Coverage (UHC) a reality, it's time to reimagine healthcare.
By treating beneficiaries more like consumers, and engaging people in the design of their own care, we will reach the Sustainable Development Goals faster, with better, affordable and more sustainable health outcomes.
Put more care & control directly in consumers' hands
We’ll partner with others to bring the latest medical and technological advances that enable consumers to “self-initiate” care. We’ll use evidence and consumer insights to create new opportunities for consumers to access information, social and emotional support, products, services, diagnostics and treatment to become active participants in their healthcare.
This will include:
• The use of two-way digital platforms that gather consumer insights, provide tailored information based on consumer needs, link to quality care, track healthcare uptake, get feedback on services and create a continuum of care.
• Diagnostic technologies like HIV self-testing that have been shown to reach more people than traditional diagnostics, helping people learn their HIV status when and where they choose.
• Subcutaneous injectable contraceptives (DPMA-SC / SubQ) that can be safely and easily administered by community health workers and through home- and self-injection.
the way YOUNG PEOPLE
We’ll partner with others to ensure all young people can access the widest range of contraceptive options, and that access to services is embraced and advocated for and by young people, their health providers, governments, families and communities. We’ll reimagine and redefine the way sexual and reproductive health and rights programs are designed, delivered, measured and evaluated. We’ll build greater trust between adolescents and the health system and build lifetime users of contraception.
In support of the Family Planning 2020 (FP2020) initiative, PSI pledged to reach 10 million people under the age of 25 with modern contraceptive methods by the end of December 2020. In December 2018, we met and surpassed that goal two years early.
Improve access to public & private primary care networks
We’ll actively partner with governments, the private sector and others to find solutions for the 400 million people globally who currently lack access to basic health services. Building on our experience of more than 15 years working with over 20,000 health providers across 25 countries, we will deploy the latest market, consumer and provider insights to help increase and sustain the equitable use of existing private or public healthcare networks. While solutions will differ country by country, and community by community, they’ll all focus on building primary healthcare systems from the consumers’ perspective, which is critical to achieving sustained use of products, services and medicines to achieve quality health outcomes.
We'll improve access in three ways:
- Advance Private Provider Quality Toward Accreditation/Certification (enable access to financing)
- Develop and demonstrate innovative and scalable models for expanding primary care
- Improve coordination of information for decision-making and increase visibility of consumers’ needs/behaviors through data engagement
in developing countries
Development assistance for health—particularly for vertical disease management interventions—is flatlining. We’ll actively partner with donors and governments to promote domestic resource mobilization to achieve UHC faster. We’ll facilitate the development and delivery of financing mechanisms at scale, such as social insurance and strategic purchasing of services from non-public primary health care access points. We’ll broaden our social enterprise business models, catering to consumers who can pay without financial hardship (another form of domestic financing) and more effectively targeting subsidy where most needed.
approach our commitments
By tapping into the expertise of 8,000 local staff in more than 50 countries around the world, we’re best placed to make impact-driven decisions.
Discover what's happening at PSI
Ask Kelly: ETHICS DURING COVID-19- Returning to In-person Research
By: Kelly O’Keefe, Research Ethics Senior Technical Advisor, PSI; Jennifer Wheeler, Deputy Director for Research, PSI; and Kristen Little, Senior Technical Advisor, Strategic Research, PSI Since the
In Memoriam to Bill Gates, Sr.
By Karl Hofmann, President & CEO, PSI Let me add our voices to those who have paid tribute to Bill Gates, Sr. His remarkable contributions to the work of
Infected and Affected: The Indirect Consequences of COVID-19 in Central America
By Jennifer Wheeler, PSI Deputy Director, Research, Paola Letona, PSI Evidence Regional Director, LAC, and Sussy Lungo, Regional Executive Director, Asociación PASMO “When you are
Five Market Indicators that Signal the Hormonal IUS will take off
By Kendal Danna, PSI Technical Advisor, Reproductive Health In 2017, with USAID support, PSI began piloting the introduction of the hormonal Intrauterine System (IUS), also